https://www.selleckchem.com/pr....oducts/thapsigargin.
lic comorbidities. We described a high prevalence of SARS-CoV-2 infection in CGL patients with a good outcome in all of them. These findings suggest that at least young CGL patients infected by SARS-COV-2 are not at higher risk of poor outcome, despite known severe metabolic comorbidities. Healthcare aims to promote good health and yet demonstrably contributes to climate change, which is purported to be 'the biggest global health threat of the 21st century'. This is happening now, with healthcare as an industry representing 4.4% of